Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss

35 Citationer (Scopus)

Abstract

To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.
OriginalsprogEngelsk
TidsskriftInternational Journal of Radiation: Oncology - Biology - Physics
Vol/bind83
Udgave nummer5
Sider (fra-til)e607-11
ISSN0360-3016
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss'. Sammen danner de et unikt fingeraftryk.

Citationsformater